A Study of a 2-dose Ebola Vaccine Regimen of Ad26.ZEBOV Followed by MVA-BN-Filo in Healthy Pregnant Women
Condition: Healthy Interventions: Biological: Ad26.ZEBOV; Biological: MVA-BN-Filo Sponsors: Janssen Vaccines & Prevention B.V.; Center for Family Health Research (CFHR); Coalition for Epidemic Preparedness Innovations (CEPI); Emory University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Ebola | Ebola Vaccine | Epidemics | Epidemiology | Pregnancy | Research | Study | Vaccines | Women